Vivacelle Bio Inc.

Welcome to Vivacelle Bio Inc.

image24

New Paradigm In Fluid Resuscitation Vivacelle Bio, Inc.

VIVACELLE BIO, Inc. is a developmental stage biotechnology company focused on creating products that utilize nanoparticle technology.  The  Company's first product, VBI-1, is a colloid non-blood volume expander that appears to be two to three times more effective than the standard treatment for hypovolemia and safer in animal studies/experiments.  On February 1, 2019, the FDA granted clearance to initiate our phase IIa clinical trial using VBI-1.  VBI-1, is primarily-designed to treat hypovolemia due to hemorrhagic shock (blood loss).The company is also developing a second product, VBI-S, to treat hypovolemia due to sepsis/septic shock.  This new class of resuscitation fluids is named, VIVACELLE. 

Vivacelle

VIVACELLE restores blood pressure, circulating volume and there by increases survival in animal models of hypovolemia.  Hypovolemia, which occurs when there is inadequate fluid volume in the blood vessels, causes the death of over a one million people globally each year.  Causes include acute blood loss from trauma, surgery, shock, sepsis, severe diarrhea and burns.  When the circulating volume is inadequate to maintain tissue perfusion and oxygenation, cellular injury and death may result.

Rapid volume replacement and re-establishment of normal blood pressure are essential to survival. Unfortunately, the current fluid treatments for hypovolemia, such as non-blood volume expanders (colloids and crystalloids), blood products and blood substitutes have proven impractical and have the potential for significant negative adverse effects.  VBI-1, a suspension of lipid droplets which form nanoparticles represents a new paradigm for use in fluid resuscitation, safely restoring blood vessel volume and reversing the effects of hypovolemia.  In addition, VBI-1 has several promising properties that may address other detrimental events contributing to cell death: 

  • Modulates Nitric Oxide (NO), (a potent vasodilator that drops the blood pressure and a precursor to highly toxic mediators)  
  • Reduces reperfusion injury 
  • Inhibits the inflammatory response 
  • Can be loaded with readily released oxygen 
  • Increases clearance of endotoxin 
  • Metabolizable and naturally-occurring components 
  • Provides an energy source

Subscribe

Sign up to hear from us about specials, sales, and events.

Contact Us

Drop us a line!

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Mailing Address:

Vivacelle Bio, Inc. 

3060 Nottingham Drive

Shreveport, LA 71115, USA


Vivacelle Bio, Inc., The Bunker Labs          

125 S. Clark St., We Work, 17th Floor,

 Chicago,  Illinois 60603 


  Vivacelle Bio Inc., The Bunker Labs 

1555 Sherman Ave., Box 326 Evanston,  

Illinois 60201


science@vivacellebio.com
 


Physical Address: Vivacelle Bio Inc.,

The Bunker Labs, 125 S. Clarke St., WeWork, 17th Floor Chicago, Illinois 60603 or 3060 Nottingham Drive Shreveport, LA 71115, USA

Hours

Mon

09:00 am – 05:00 pm

Tue

09:00 am – 05:00 pm

Wed

09:00 am – 05:00 pm

Thu

09:00 am – 05:00 pm

Fri

09:00 am – 05:00 pm

Sat

Closed

Sun

Closed